Outcomes and Follow-Up after Hepatitis C Eradication with Direct-Acting Antivirals

Treatment of hepatitis C (HCV) has been revolutionized with the introduction of direct-acting antivirals (DAAs). Patients can be treated at more advanced stages of liver disease, with a growing number of cirrhotic patients achieving sustained virological response (SVR). Long-term outcomes for cured...

Descripción completa

Detalles Bibliográficos
Autores principales: Lynch, Erica Nicola, Russo, Francesco Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056757/
https://www.ncbi.nlm.nih.gov/pubmed/36983196
http://dx.doi.org/10.3390/jcm12062195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056757/
https://www.ncbi.nlm.nih.gov/pubmed/36983196
http://dx.doi.org/10.3390/jcm12062195

Ejemplares similares